Yes, you can sell a private label retinaldehyde body serum in the EU and UK, but the regulatory pathway is more structured than in the US, and concentration limits are explicitly defined by regulators.
In the EU, retinaldehyde (INCI: Retinal) in body lotion and body serum products is permitted at a maximum concentration of 0.05% as confirmed in the SCCS Opinion of March 2022. Face products also carry a 0.05% cap. Products intended for use on large body surface areas by potentially pregnant consumers must include a mandatory warning: do not use on large areas of skin, avoid sun exposure, and do not use if pregnant. These are not optional advisory statements — they are required label text under EU Cosmetics Regulation 1223/2009.
To place a retinaldehyde body serum on the EU market, you must have a Responsible Person (RP) established in the EU who holds the Product Information File (PIF) and notifies the product via the Cosmetic Products Notification Portal (CPNP). The RP does not have to manufacture the product but must be reachable by EU authorities. RP services are available from third-party regulatory consultancies for €200–€600 per year per SKU.
The UK post-Brexit operates a parallel system. You need a UK Responsible Person (separate from your EU RP), and products must be notified via the UK OPSS Submit Cosmetic Product Notifications service (commonly called the UK CPNP). UK concentration limits for retinoids currently mirror the EU's 2022 SCCS position, but this can diverge in future as UK MHRA issues its own scientific opinions.
A Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor — who must hold relevant toxicology or pharmacy credentials — is mandatory for both EU and UK market entry. The CPSR documents that your specific formula at your specific retinaldehyde concentration is safe for its intended use. Budget £800–£1,500 for a CPSR from a UK-based safety assessor, or €800–€2,000 for an EU equivalent.
Label requirements in both markets mandate the full INCI ingredient list (Retinal must appear at correct rank by concentration), a durable batch number, a Period After Opening (PAO) symbol, and net weight in metric units. For a retinaldehyde product, a PAO of 6M (six months after opening) is conservative but defensible given the active's oxidative sensitivity.
Common first-timer mistake: assuming a US formulation and label can be shipped directly to EU customers without any modification. Custom duty, labeling compliance, and CPNP notification are all required before first sale. Work with an EU regulatory consultant in parallel with your manufacturer — don't leave it until after production.
Ingredients in this answer: Retinal
Read the full guide on Private Label Retinaldehyde Body Serum Manufacturer Low MOQ →